United States: FDA Approves First Cellular Therapy For Treatment Of Unresectable Or Metastatic Melanoma - Goodwin Procter LLP

United States: FDA Approves First Cellular Therapy For Treatment Of Unresectable Or Metastatic Melanoma - Goodwin Procter LLP

Mondaq

Published

On February 16, 2024, the FDA approved Iovance's AMTAGVI, the first approved cellular therapy for the treatment of adult patients with unresectable or metastatic melanoma.

Full Article